Filing Details
- Accession Number:
- 0001104659-19-036492
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-19 21:03:43
- Reporting Period:
- 2019-06-18
- Accepted Time:
- 2019-06-19 21:03:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1481512 | Ra Pharmaceuticals Inc. | RARX | Pharmaceutical Preparations (2834) | 262908274 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1688199 | Simon Read | C/O Ra Pharmaceuticals, Inc. 87 Cambridgepark Drive Cambridge MA 02140 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-18 | 10,000 | $2.87 | 16,234 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-06-18 | 9,586 | $22.21 | 6,648 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-06-18 | 414 | $23.09 | 6,234 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to buy) | Disposition | 2019-06-18 | 10,000 | $0.00 | 10,000 | $2.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 106,142 | 2026-06-16 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2019.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $22.00 to $22.81. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $23.00 to $23.21. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- These stock options vest over four (4) years beginning on April 4, 2016, at a rate of twenty-five percent (25%) after 12 months, and in thirty-six (36) equal monthly installments thereafter.
Billionaire Hedge Funds
